Researchers have developed a new, low-cost blood test capable of detecting multiple types of cancer and liver diseases at an early, treatable stage.
The test identifies specific biomarkers in the blood, providing clinicians with a faster and more accessible diagnostic tool compared to traditional imaging methods.
Clinical trials are currently underway to validate the test's accuracy across diverse patient populations, with potential for widespread implementation in primary care settings.